The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...

The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

Thanks to a Takeda approval Thursday, patients now have a drug to tackle a rare inherited blood clotting disorder. The U.S. FDA has given a green light to Takeda’s Adzynma, the first recombinant ...

A recombinant form of human ADAMTS13 approved for a different condition helped to save the life of a young mother with immune thrombotic thrombocytopenic purpura. A team led by investigators from ...

A woman has been honoured for her work supporting others living with a rare blood disorder. Jo McIntyre, founder of ...

Every day, Sanofi employees work to chase the miracles of science and improve people’s lives by asking themselves “what if?” Our work is rooted in scientific curiosity centered on the question: What ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

Jo McIntyre, founder of TTPNetwork and a former domestic abuse reduction coordinator, has been awarded the British Empire Medal (BEM) in the King’s New Year Honours. The award recognises her 28 years ...